Ling Zhao

The paper develops a chimeric vaccine platform that delivers self-assembling particles, triggering strong lung immunity and broad virus protection across species.

This paper introduces ScreenDL, a deep learning model that predicts effective cancer therapies using tumor omic and drug screening data, outperforming existing methods in preclinical trials.

This study identifies TRIM72 as a host factor that restricts lyssavirus infection by promoting ubiquitination and proteasomal degradation of the viral matrix protein.